Success Stories: EB-1A Approved for Senior Post-doctoral Associate in California in the Field of Clinical Medicine and Endocrinology
Client’s Testimonial:
Hi, I just received an email from USCIS earlier, saying my I140 is approved! Thank you very much for your help on my case!
On September 11th, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for a Senior Post-doctoral Associate in the Field of Clinical Medicine and Endocrinology (Approval Notice)
Position at the Time of Case Filing: Senior Post-doctoral Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: September 11th, 2015
Processing Time: 5 Months, 28 Days
In this case, the client that we had the opportunity to work with was a senior post-doctoral associate from China in the field of clinical medicine and endocrinology. Specifically, our client’s specialized research has focused on developing a cure for late stage diabetes. Her work had resulted in 25 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 132 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 10 manuscripts for 7 distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] therapy is truly quite remarkable in that it not only reverses the autoimmunity that destroys the islets, but also stimulates regeneration among islet beta cells. This contribution offers a far more effective therapy than conventional ones, a fact that several news outlets has felt important enough to share with the public.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of clinical medicine and endocrinology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 5 months and 28 days.